Clinical Study

IBS symptoms reduced with UAS multi-species probiotic blend

Format: PDF file | Document type: Clinical Study | Promoted Content

This Clinical Study has been written by UAS Laboratories , and any views and opinions expressed do not necessarily reflect those of

IBS symptoms reduced with UAS multi-species probiotic blend

UAS Probiotic Blend 003 is a multi-species probiotic blend recently used in a clinical study of IBS patients. The probiotic blend contains the superstrain, Lactobacillus acidophilus DDS-1, Bifidobacterium longum UABL-14, Bifidobacterium bifidum UABB 10, Bifidobacterium lactis UABLA 12 and FOS at a potency of 12 billion CFU/g. It was used to treat IBS patients for 8 weeks.

Physicians looked for at least a 50% reduction in the six most common symptoms of IBS. At the end of 8 weeks, between 72% and 92% of patients were experiencing positive results in one or more symptoms. This probiotic blend is available from UAS Laboratories, Inc. Eden Prairie, MN 55344 USA (

Latest content from UAS Laboratories

show more

Related resources from UAS Laboratories

Show more

Supplier info centre